Nöroblastomlu Bir Olguda VİP İlişkili Diyarenin Yönetimi

Cilt: 38 Sayı: 3 1 Eylül 2013
Begül Yağcı-küpeli , Ali Varan , Turan Bayhan , Hülya Demir , Münevver Büyükpamukçu
PDF İndir
EN TR

Management of VIP Associated Diarrhea in a Case with Neuroblastoma

Abstract

Watery diarrhea associated with hypokalemia and achlorhydria (WDHA) syndrome is commonly caused by vasoactive intestinal peptide (VIP) secreting tumors in adults and generally associated with neural crest tumors in pediatric population. VIP secretion is associated with neuroblastic cell differentiation. Octreotide treatment can be a choice for diarrhea in such cases. However, its benefit is controversial and surgery is usually needed. A 14-month-old female with diagnosis of inoperable undifferantiated intraabdominal neuroblastoma who developed chronic diarrhea at first year of chemotherapy is reported. Octreotide treatment was used to control diarrhea. Because of the failure of octreotide treatment, debulking surgery was performed and diarrhea subsided after the surgery.

Keywords

Neuroblastoma, diarrhea, octreotide

Kaynakça

  1. Verner JV, Morrison AS. Islet cells tumor and a syndrome of refractory watery diarrhea and hypokalaemia. Am J Med. 1958;25:374–80. Bourdeaut F, de Carli E, Timsit S, et al. VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Société Française des Cancers de I’Enfant (SFCE). Pediatr Blood Cancer. 2009; 52:585-90.

Kaynak Göster

MLA
Yağcı-küpeli, Begül, vd. “Nöroblastomlu Bir Olguda VİP İlişkili Diyarenin Yönetimi”. Cukurova Medical Journal, c. 38, sy 3, Eylül 2013, ss. 528-30, https://izlik.org/JA27NF22AC.